Ji Hyun Kim, M.D.

(310) 750-1715
Ji Hyun Kim, M.D.
Radiation Oncologist
Clinical Expertise
  • Breast Cancer
  • Central Nervous System Cancers
  • Lung Cancer
  • Skin Cancer
  • Prostate Cancer
  • Gastrointestinal Cancers
  • Gynecologic Cancers
  • Head and Neck Cancers
  • Stereotactic Radiosurgery
  • Stereotactic Body Radiation Therapy (SBRT)/Stereotactic Ablative Radiation Therapy (SABR)
Research Area
  • Breast Cancer
  • Brain Metastases
Academic Appointments
  • Assistant Clinical Professor, Department of Radiation Oncology
Clinical Teams
Radiation Oncology
Lung Cancer
Skin Cancer and Melanoma
Breast Cancer

Ji Hyun Kim, M.D. is a radiation oncologist at City of Hope | South Bay.

Dr. Kim received her undergraduate degree in biochemistry from the University of California Davis. She went on to earn a Master of Medical Sciences degree followed by her medical doctorate from Drexel University College of Medicine in Philadelphia. She completed an internship in internal medicine at the University of Nevada School of Medicine in Las Vegas before going on to complete her radiation oncology residency at City of Hope.

Dr. Kim is board certified in radiation oncology, and is a member in good standing with numerous professional societies including the American Society for Clinical Oncology, the American Society for Radiation Oncology and the Radiological Society of North America, to name a few. She has published in the peer-reviewed literature and has been involved with several innovative translational research protocols here at City of Hope.

Location

Education & Experience

Degrees

  • 2008, M.D., Drexel University College of Medicine, Philadelphia, PA
  • 2004, M.M.S., Drexel University College of Medicine, Philadelphia, PA
  • 2001, B.S., University of California Davis, Davis, CA

Residency

  • 2012–2013, Chief Resident, Radiation Oncology, City of Hope, Duarte, CA
  • 2009–2011, Resident, Radiation Oncology, City of Hope, Duarte, CA

Internship

  • 2008–2009, Intern, Internal medicine, University of Nevada School of Medicine, Las Vegas, NV

Professional Experience

  • 2013–present, Assistant Clinical Professor, Department of Radiation Oncology, City of Hope, Torrance, CA

Publications

  • Kim JH, Liu B, Liu A, Williams TM. "Hippocampal Sparing Whole Brain Radiation Therapy: 2 Arc Coplanar and 4 Arc Noncoplanar Planning Comparison." Manuscript in preparation (2023).
  • Kim JH, Stein A, Rosenthal J, Schultheiss TE, Liu A, Palmer J, Tsai N, Forman S, Kogut N, Wong JY. “Extramedullary (EM) Relapse Following Total Marrow and Lymphoid Irradiation (TMLI) in Patients Undergoing Allogeneic Hematopoietic Cell Transplant (HCT).” Int J Radiat Oncol Biol Phys. 2014;89(1):75-81
  • Kim JH, Wong P, Shively JE, Wong JY. “64Cu-labeled targeted nanoparticle PET imaging in prostate cancer.” Manuscript in preparation (2013).
  • Kim JH, Li L, Quang TS, Emrich JG, Yaeger TE, Jenrette JM, Cohen SC, Black P, Brady LW. “Phase II trial of anti-epidermal growth factor receptor radioimmunotherapy in the treatment of anaplastic astrocytoma.” J of Rad Oncol September 30, 2012 Online first.
  • Han CH, Nguyen K, Kim JH, Pezner RD, Schultheiss TE, Wong JY. “Radiobiologic evaluation of lung toxicity in treatment plan quality comparisons for hypofractionated stereotactic body radiotherapy using relative damaged volume modeling.” Med. Phys. 2011; 38(6):i-3908.
  • Daugherty LC, Morales S, Fisher B, Li L, Kim J, Quang T, Emrich J, Yaeger T, Komarnicky L, Brady LW. “A phase II study of surgical excision, temozolomide, radiotherapy, and anti-EGFR radioimmunotherapy (EXTRA) as adjuvant therapy in high-grade gliomas.” Int J Radiat Oncol Biol Phys. 2011; 81(2 Suppl):S180.
  • Li L, Quang TS, Gracely EJ, Kim JH, Emrich JG, Yaeger TE, Jenrette JM, Cohen SC, Black P, Brady LW. “A phase II study of anti-epidermal growth factor receptor radioimmunotherapy in the treatment of glioblastoma multiforme.” J Neurosurg. 2010; 113(2):192-198.
  • Kim JH, Li L, Quang TS, Emrich JG, Yaeger TE, Jenrette JM, Cohen SC, Brady LW. “Anti-EGFR radioimmunotherapy in the treatment of astrocytoma with anaplastic foci (AAF)”. Int J Radiat Oncol Biol Phys. 2008; 72(1 Suppl):S53.
  • Kim J, Li L, Quang T, Emrich J, Yaeger T, Jenrette J, Cohen S, Brady L. “Anti-EGFR radioimmunotherapy in the treatment of astrocytoma with anaplastic foci (AAF): a 20 year experience.” Am J Clin Oncol. 2008; 31(6):620-621.
  • Li L, Quang TS, Gracely E, Emrich JG, Kim J, Yaeger TE, Jenrette JM, Brady LW. “Glioblastoma multiforme: a 20-year experience using radioimmunotherapy and temozolomide.” Neuro Oncol. 2007; 9(4):508.
  • Li L, Quang TS, Gracely EJ, Emrigh JG, Kim J, Yaeger TE, Jenrette JM, Cohen SC, Brady LW. “Radioimmunotherapy and temozolomide in the treatment of glioblastoma multiforme: a 20 year experience.” Int J Radiat Oncol Biol Phys. 2007; 69(3 Suppl):S48.
  • Blackwood-Chirchir A, Tretiakova M, Yuan W, Singh Y, Kim J, Das T, Garber J, Klein C, Olopade O, Weber B. “p27 and pAKT Expression in BRCA-1 Associated and Sporadic Breast Tumors.” J Clin Oncol 2004 22(14S):9609.

Ratings & Reviews

Ratings and reviews below are gathered from the Press Ganey Clinician and Group Consumer Assessment of Healthcare Providers and Systems (CG CAHPS) survey. CG CAHPS is a standardized survey that is used to measure a patient's experience in the physician office setting. Ratings are an average of all responses to questions about a provider's care, with five stars being the highest.
5.0
Provider explain in way you understand
5.0
Provider listen carefully to you
5.0
Show respect for what you say
5.0
Spend enough time with you
4.9
Recommend this provider office
4.9
Know important info medical history
4.9
Rate provider 0-10
03/03/26
The best in excellent care - Verified patient
03/03/26
I gladly recommend family and friends - Verified patient
02/26/26
Dr Kim is outstanding. Responds in a positive manner with details and facts of the procedure - highly recommend. - Verified patient
12/21/25
Good experience - Verified patient
10/23/25
Good - Verified patient